Abstract
Regenerative medicine, though has recently become an increasingly researched field, has been around for many years, predominantly in the form of prolotherapy. The proposed mechanism of action of prolotherapy is to introduce a local irritant in order to cause cell death, thereby promoting the release of various growth factors. Prolotherapy is most commonly used for chronic musculoskeletal conditions, typically with tendinoses, ligamentous sprains, or articular cartilage damage, as in knee osteoarthritis. Furthermore, prolotherapy injections are commonly thought to be safe procedures with relatively few contraindications and thus pose to be a viable nonsurgical treatment option.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Suggested Reading
Nih Fact Sheets – Regenerative Medicine. https://report.nih.gov/nihfactsheets/ViewFactSheet.aspx?csid=62.
Hackett GS, Hemwall GA, Montgomery GA. Ligament and tendon relaxation treated by prolotherapy. 5. Gustav A. Hemwall: Oak Park; 1993.
Rabago D, Slattengren A, Zgierska A. Prolotherapy in primary care practice. Prim Care. 2010;37:65–80.
Hauser RA, Lackner JB, Steilen-Matias D, Harris DK. A systematic review of dextrose prolotherapy for chronic musculoskeletal pain. Clinical medicine insights: Arthritis Musculoskelet Disord. 2016: 9.
US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics Health. With Chartbook on trends in the health of Americans. Hyattsville: National Center for Health Statistics; 2006. DHHS Publication No 2006 1232
United States Bone and Joint Decade. The burden of musculoskeletal diseases in the United States. 1st ed. Rosemont: American Academy of Orthopaedic Surgeons; 2008. p. 42.
Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC). 2017. Retrieved 23 Apr 2018, from https://report.nih.gov/categorical_spending.aspx.
Jenson K, Rabago D, Best T, Patterson J, Vanderby R Jr. Response of knee ligaments to prolotherapy in a rat model. Am J Sports Med. 2008;36(7):1347–57.
Banks AR. The rationale for prolotherapy. J Orthop Med. 1991;13.
Morath O, Kubosch EJ, Taeymans J, Zwingmann J, Konstantinidis L, Südkamp NP, Hirschmüller A. The effect of sclerotherapy and prolotherapy on chronic painful Achilles tendinopathy-a systematic review including meta-analysis. Scandinavian J Med Sci Sports. 2017;28(1):4–15. https://doi.org/10.1111/sms.12898.
Jensen KT, Rabago DP, Best TM, Patterson JJ, Vanderby R. Response of knee ligaments to prolotherapy in a rat injury model. Am J Sports Med. 2008;36(7):1347–57.
Housner JA, Jacobson JA, Misko R. Sonographically guided percutaneous needle tenotomy for the treatment of chronic tendinosis. J Ultrasound Med. 2009;28(9):1187–92. https://doi.org/10.7863/jum.2009.28.9.1187.
Jacobson JA, Rubin J, Yablon CM, Kim SM, Kalume-Brigido M, Parameswaran A. Ultrasound-guided fenestration of tendons about the hip and pelvis. J Ultrasound Med. 2015;34(11):2029–35. https://doi.org/10.7863/ultra.15.01009.
Torres F. An assessment on the ultrasound guided dextrose prolotherapy for persistent coccygeal pain: a case series and review of literature. Altern Integr Med. 2014;03(02) https://doi.org/10.4172/2327-5162.1000155.
Miller MR, Mathews RS, Reeves KD. Treatment of painful advanced internal lumbar disc derangement with intradiscal injection of hypertonic dextrose. Pain Phys. 2006;9(2):115–21.
Martins CA, Bertuzzi RT, Tisot RA, et al. Dextrose prolotherapy and corticosteroid injection into rat Achilles tendon. Knee Surg Sports Traumatol Arthrosc. 2012;20:1895–900.
Ahn KH, Kim HS, Lee WK, et al. The effect of the prolotherapy on the injured Achilles tendon in a rat model. J Korean Acad Rehabil Med. 2002;26:332–6.
Kim HJ, Jeong TS, Kim WS, et al. Comparison of histological changes in accordance with the level of dextrose-concentration in experimental prolotherapy model. J Korean Acad Rehabil Med. 2003;27:935–40.
Bollen S. Epidemiology of knee injuries: diagnosis and triage. Br J Sports Med. 2000;34(3).
Heidari B. Knee osteoarthritis prevalence, risk factors, pathogenesis and features: part I. Caspain J Int Med. 2011;2(2).
Michael J, Schlüter-Brust K, Eysel P. The epidemiology, etiology, diagnosis, and treatment of osteoarthritis of the knee. Dtsch Arztebl Int. 2010;107:152–62.
Rabago D, Zgierska A, Fortney L, et al. Hypertonic dextrose injec- tions (prolotherapy) for knee osteoarthritis: results of a single-armed uncontrolled study with 1-year follow-up. J Altern Complement Med. 2012;18(4):408–14.
Rabago D, Patterson JJ, Mundt M, Kifjowski R, Grettie J, Segal NA, Zgierska A. Dextrose prolotherapy for knee osteoarthritis: a randomized controlled trial. Ann Fam Med. 2013;11(3):229–37.
Reeves KD, Hassanein K. Randomized prospective double-blind placebo controlled study of dextrose prolotherapy for knee osteoarthritis with or without ACL laxity. Altern Ther Health Med. 2000;6(2):68–74. 77-80
Sit RW, Chung VC, Reeves KD, Rabago D, Chan KK, Chan DC, et al. Hypertonic dextrose injections (prolotherapy) in the treatment of symptomatic knee osteoarthritis: a systematic review and meta-analysis. Sci Rep. 2016;6(1).
Jumper’s Knee. 2017. Retrieved 07 Apr 2018, from https://emedicine.medscape.com/article/89569-overview#a8.
Kujala UM, Kvist M, Heinonen O. Osgood-Schlatters disease in adolescent athletes. Am J Sports Med. 1985;13(4):236–41.
Wall EJ. Osgood-Schlatter disease: practical treatment for a self-limiting condition. Phys Sportsmed. 2010;38(4):29–34.
Topol GA, Podesta LA, Reeves KD, Raya MF, Fullerton BD, Yeh H. Hyperosmolar dextrose injection for recalcitrant Osgood-Schlatter disease. Pediatrics. 2011;128(5):e1121–8.
Maughan K. n.d. Achilles tendinopathy and tendon rupture. Retrieved 07 Apr 2018, from https://www.uptodate.com/contents/achilles-tendinopathy-and-tendon-rupture.
Sanderson LM, Bryant A. Effectiveness and safety of prolotherapy injections for management of lower limb tendinopathy and fasciopathy: a systematic review. J Foot Ankle Res. 2015;8(1).
Maxwell NK, Ryan M, Taunton J, Gillies JH, Wong A. Sonographically guided intratendinous injection of hyperosmolar dextrose of the Achilles tendon: a pilot study. Am J Roentgenol. 2007;189(4):W215–20.
Ryan M, Wong A, Taunton J. Favourable outcomes after sonographically guided inratendinous injection of hyperosmolar dextrose for chronic insertional and midportion Achilles tendinosis. Am J Roentgenol. 2010;194:1047–53.
Goff J, Crawford R. Diagnosis and treatment of plantar fasciitis. Am Fam Physician. 2011;84(6):676–82.
Ryan M, Wong A, Gillies J, Wong J, Taunton J. Sonographically guided intratendinous injections of hyperosmolar dextrose/lidocaine: a pilot study for the treatment of chronic plantar fasciitis. Br J Sports Med. 2009;43:303–6.
Kim E, Lee J. Autologous platelet rich plasma versus dextrose prolotherapy for the treatment of chronic recalcitrant plantar fasciitis. Phys Med Rehabil Int. 2014;6:152–8.
Van der Windt D, Koes B, De Jong B, Bouter L. Shoulder disorders in general practice: incidence, patient characteristics, and management. Ann Rhem Disease. 1995;54(12):959–64.
Buchbinder R, Green S, Youd JM. Corticosteroid injections for shoulder pain. Cochrane Database Syst Rev. 2003;(1):Cd004016.
Seven MM, Ersen O, Akpancar S, Ozkan H, Turkkan S, Yıldız Y, et al. Effectiveness of prolotherapy in the treatment of chronic ro- tator cuff lesions. Orthop Traumatol Surg Res. 2017;103(3):427–33. https://doi.org/10.1016/j.otsr.2017.01.003.
Lebiedziński R, Synder M, Buchcic P, Polguj M, Grzegorzewski A, Sibiński M. A randomized study of autologous conditioned plasma and steroid injections in the treatment of lateral epicondylitis. Int Orthop. 2015;39(11):2199–203.
Bisset L, Beller E, Jull G, et al. Mobilization with movement and exercise, corticosteroid injection or wait and see. BMJ. 2006;333:939. [PubMed: 17012266]
Rabago D, Lee KS, Ryan M, Chourasia AO, Sesto ME, Zgierska A, et al. Hypertonic dextrose and morrhuate sodium injections (prolotherapy) for lateral epicondylosis (tennis elbow). Am J Phys Med Rehabil. 2013;92(7):587–96. https://doi.org/10.1097/phm.0b013e31827d695f.
Scarpone M, Rabago DP, Zgierska A, Arbogast G, Snell E. The efficacy of prolotherapy for lateral epicondylosis: a pilot study. Clin J Sport Med. 2008;18(3):248–54. https://doi.org/10.1097/jsm.0b013e318170fc87.
Zhang Y, Niu J, Kelly-Hayes M, Chaisson C, Aliabadi P, Felson D. Prevalence of symptomatic hand osteoarthritis and its impact on functional status among the elderly: the Framingham study. Am J Epidemiol. 2002;156(11):1021–7. https://doi.org/10.1093/aje/kwf141.
Kroon F, Rubio R, Schoones J, Kloppenburg M. Intra-articular therapies in the treatment of hand osteoarthritis: a systematic literature review. Osteoarthr Cartil. 2016;24 https://doi.org/10.1016/j.joca.2016.01.952.
Reeves KD, Hassanein K. Randomized, prospective, placebo-controlled double-blind study of dextrose prolotherapy for osteoarthritic thumb and finger (DIP, PIP, and trapeziometacarpal) joints: evidence of clinical efficacy. J Altern Complement Med. 2000;6(4):311–20. https://doi.org/10.1089/10755530050120673.
Jahangiri A, Moghaddam FR, Najafi S. Hypertonic dextrose versus corticosteroid local injection for the treatment of osteoarthritis in the first carpometacarpal joint: a double-blind randomized clinical trial. J Orthop Sci. 2014;19(5):737–43. https://doi.org/10.1007/s00776-014-0587-2.
Feldman, M. D. (2004). Prolotherapy for the treatment of chronic low back pain. California Technology Assessment Forum.
Klein RG, Eek BC, DeLong WB, Mooney V. A randomized double- blind trial of dextrose-glycerine phenol injections for chronic, low back pain. J Spinal Disord. 1993;6:23–33.
Ongley MJ, Klein RG, Dorman TA, Eek BC, Hubert LJ. A new approach to the treatment of chronic low back pain. Lancet. 1987;2(8551):143–6.
Hooper RA, Yelland M, Fonstad P, Southern D. Prospective case series of litigants and non-litigants with chronic spinal pain treated with dextrose prolotherapy. Int Musculoskelet Med. 2011;33(1):15–20.
Bernard TN Jr, Kirkaldy-Willis WH. Recognizing specific characteristics of nonspecific low back pain. Clin Orthop. 1987;217:266–80.
Frost S, Wheeler M, Fortin J, Vilensky J. The sacroiliac joint: anatomy, physiology and clinical significance. Pain Physician. 2006;9:61–8.
Kim WM, Lee HG, Jeong CW, Kim CM, Yoon MH. A randomized controlled trial of intra-articular prolotherapy versus steroid injection for sacroiliac joint pain. J Altern Complement Med. 2010;16(12):1285–90. https://doi.org/10.1089/acm.2010.0031.
Danielle S, C., M. J., Ross, H., Barbara, W., & Sarah, S. Chronic neck pain: making the connection between capsular ligament laxity and cervical instability. Open Orthop J. 2014;8(1):326–45. https://doi.org/10.2174/1874325001408010326.
Slade GD. Epidemiology of temporomandibular joint disorders and related painful conditions. Mol Pain. 2014;10(Suppl 1):O16.
Ebrahim S, Montoya L, Busse JW, Carrasco-Labra A, Guyatt GH. The effectiveness of splint therapy in patients with temporomandibular disorders. J Ame Dental Assoc. 2012;143(8):847–57. https://doi.org/10.14219/jada.archive.2012.0289.
Scrivani SJ, Mehta NR. 2016. Temporomandibular disorders in adults. Retrieved 22 Apr 2018, from https://www.uptodate.com/contents/temporomandibular-disorders-in-adults.
Refai H. Long-term therapeutic effects of dextrose prolotherapy in patients with hypermobility of the temporomandibular joint: a single-arm study with 1-4 years’ follow up. Br J Oral Maxillofac Surg. 2017;55(5):465–70. https://doi.org/10.1016/j.bjoms.2016.12.002.
Dagenais S, Ogunseitan O, Haldeman S, et al. Side effects and adverse events related to intraligamentous injection of sclerosing solutions (prolotherapy) for back and neck pain: a survey of practitioners. Arch Phys Med Rehabil. 2006;87:909–13.
Rahimzadeh P, Imani F, Faiz SH, Entezary SR, Zamanabadi MN, Alebouyeh MR. The effects of injecting intra-articular platelet-rich plasma or prolotherapy on pain score and function in knee osteoarthritis. Clin Interv Aging. 2018;13:73–9. https://doi.org/10.2147/cia.s147757.
Kim E, Lee JH. Autologous platelet-rich plasma versus dextrose prolotherapy for the treatment of chronic recalcitrant plantar fasciitis. Pm&r. 2014;6(2):152–8. https://doi.org/10.1016/j.pmrj.2013.07.003.
Ryan M, Wong A, Rabago D, Lee K, Taunton J. Ultrasound-guided injections of hyperosmolar dextrose for overuse patellar tendinopathy: a pilot study. Br J Sports Med. 2011;45(12):972–7.
Labella CR, Hennrikus W, Hewett TE. Anterior cruciate ligament injuries: diagnosis, treatment, and prevention. Pediatrics. 2014;133(5).
Dorman TA. Treatment for spinal pain arising in ligaments–using prolotherapy: a retrospective survey. J Orthop Med. 1991;13:13–9.
Dorman T. Whiplash injuries: treatment with prolotherapy and a new hypothesis. J Orthop Med. 1999;21:13–21.
Iseminger T, Palaikis R. A retrospective study of prolotherapy. San Luis Obispo: Cal State Polytechnic, Biological Sciences Department; honors paper (undergraduate); 1995:15.
Lopez RG, Jung H. Achilles tendinosis: treatment options. Clin Orthop Surg. 2015;7(1):1. https://doi.org/10.4055/cios.2015.7.1.1.
Center for Disease Control and Prevention. National ambulatory medical care survey. 2010. Available at http://www.cdc.gov/nchs/ahcd.htm.
Block J, Berkoff M. Clinical utility of ultrasound guidance for intra-articular knee injections: a review. Clin Interv Aging. 2012:89–95.
Rabago D, van Leuven L, Benes L, Fortney L, Slattengren A, Grettie J, Mundt M. Qualitative assessment of patients receiving prolotherapy for knee osteoarthritis in a multimethod study. J Altern Complement Med. 2016;22:983–9.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Kajbaf, J. (2023). Prolotherapy. In: Hunter, C.W., Davis, T.T., DePalma, M.J. (eds) Regenerative Medicine . Springer, Cham. https://doi.org/10.1007/978-3-030-75517-1_2
Download citation
DOI: https://doi.org/10.1007/978-3-030-75517-1_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-75516-4
Online ISBN: 978-3-030-75517-1
eBook Packages: MedicineMedicine (R0)